France and Germany have a huge responsibility for the future of the European project
In Conversation
One can say France is back, however, there is still a lot of work to do, as we have been losing expertise and manufacturing capacities to…
In terms of research, we have invested EUR 100 million to conduct 100-150 clinical trials a year, including 4,000 patients, with a particular focus on early-phase…
Vaccination is the most effective public health intervention in medicine after clean water.
In France, we start to see hospitals coming to us, but also clinical diagnostic laboratories because for a lot of tests in oncology they use the…
Our system brings between 3500 and 4000 patients into clinical trials every year, which makes it the largest such program in Europe and for early clinical…
The best investment is in healthcare and the Macron administration has been made aware of this
Our speciality is the extraction, purification and concentration of active molecules derived from plant matter and sourced from expert growers from more than 40 countries around…
Eric Del Cotto, general manager of Owen Mumford Southern Europe and Northern Africa, explains the challenges in market access for SMEs in France. He also gives…
France is renowned for bringing together academics and technology institutes. They work brilliantly together, but the country is missing the investment steps to commercialize the solutions
We simply could not have started Avalun in France without being in Grenoble. There a plethora of reasons, but the prime one is people
Our members are committed to finding the “healthcare integrated solutions of tomorrow,” utilizing AI and complex innovative technology
